ROBERT PEDEN EYE SURGERY LIMITED
Opportunity 70/100 (strong), bankability 70/100. High owner-dependency — earn-out structure likely required for clean transition. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Broaden director team. Sole director creates succession risk and reduces buyer comfort. Appoint a second director or strong #2. Most likely exit: strategic trade sale (65/100).
Data confidence
Overall: medium (79/100)Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.
Solid opportunity signal. Worth a dedicated memo and management meeting.
Key financials
2 years extracted from filed iXBRL accountsHover to see exact values · click legend to toggle series
Financials
Extracted from Companies House accounts · FRS 102| Metric | 2025-04-30 | 2024-04-30 |
|---|---|---|
| Average employees | 100 | 100 |
Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.
1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.
Available from the Pro tier upwards.
See pricing →Recent activity
- • 1 confirmation-statement
- • 1 officers
- • 1 confirmation-statement
- • 1 officers
- • 1 resolution
- • 1 confirmation-statement
- • 1 officers
- • 1 resolution
Corporate timeline (13 events)Click to expand
- 2026-04-30📄change-person-director-company-with-change-dateofficers · CH01
- 2026-03-25📄resolutionresolution · RESOLUTIONS
- 2026-03-24📄memorandum-articlesincorporation · MA
- 2026-03-24📄capital-allotment-sharescapital · SH01
- 2026-02-17📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2024-10-31📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2024-01-30📄accounts-with-accounts-type-micro-entityaccounts · AA
- 2023-01-23📄capital-allotment-sharescapital · SH01
- 2023-01-18📄memorandum-articlesincorporation · MA
- 2023-01-18📄resolutionresolution · RESOLUTIONS
- 2022-04-22🏢Company incorporatedAs ROBERT PEDEN EYE SURGERY LIMITED
- 2022-04-22➕PEDEN, Robert George, Dr appointeddirector
- 2022-04-22📄incorporation-companyincorporation · NEWINC
Owner dependency
The business appears inseparable from the founder. Acquisition without a serious earn-out or meaningful transition period would likely destroy value.
- +Sole director: Only one active director — all governance concentrated on one person.
- +Founder name in company name: Company name contains director surname "PEDEN" — strong identity link between founder and business.
Succession & seller-readiness
Some succession indicators present. Worth watching; approach if sector/strategy fits.
- primarySole active director: Only one director in control. No visible successor — buyers solve the succession problem.
Red flags
cleanShareholders & ownership
1 active beneficial owner · dominant holder ≥75%| Name | Shares | Voting rights | Nature of control | Notified |
|---|---|---|---|---|
Dr Robert George Peden Individual · British · DOB 06/1984 · age 42 | 75–100% | 75–100% | board control75-100% shares · 75-100% voting · board control | 22/04/2022 |
From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.
Radial SVG graph showing every company connected via shared directors, colour-coded by status.
Available from the Pro tier upwards.
See pricing →Similar companies
Active · Healthcare & medical · EH postcode area| Company | Est. value | Turnover | Net worth | Staff | Age | Opp | Director |
|---|---|---|---|---|---|---|---|
| SUMMIT HEALTHCARE (WISHAW) LIMITED→ SC182649 · est 1998 | £14.49M £10.43M–£18.54M | — | — | 0 | 28y | 84 | 60y |
| AYRSHIRE HOSPITALS LIMITED→ SC248921 · est 2003 | £4.40M £3.17M–£5.63M | — | — | 0 | 23y | 84 | 64y |
| STONEHOUSE HOSPITALS LIMITED→ SC251033 · est 2003 | £706.3k £508.5k–£904.0k | — | — | 0 | 22y | 92 | 64y |
| RENAISSANCE CARE (UK) LTD→ SC379961 · est 2010 | £389.9k £280.7k–£499.1k | — | — | 400 | 15y | 84 | 69y |
| GLOBAL NETWORK OF SEX WORK PROJECTS LIMITED→ SC349355 · est 2008 | £93.1k £67.0k–£119.1k | — | — | 4 | 17y | 83 | 59y |
| PRESTIGE NURSING (SCOTLAND) LIMITED→ SC143810 · est 1993 | — | — | — | 28800 | 33y | 84 | 63y |
| ANSWER PROJECT→ SC212773 · est 2000 · no financials extracted | — | — | — | — | 25y | 83 | 79y |
| CRANSTON NURSERIES LIMITED→ SC253519 · est 2003 | — | — | £360.3k | — | 22y | 83 | 76y |
| EDINBURGH SPORTS INJURY CLINIC LIMITED→ SC245755 · est 2003 | — | — | £97.9k | — | 23y | 83 | 61y |
| ELDER HOMES LIMITED→ SC154896 · est 1994 · no financials extracted | — | — | — | — | 31y | 83 | 80y |
| FLORABANK HOME LIMITED→ SC170166 · est 1996 · no financials extracted | — | — | — | — | 29y | 83 | 81y |
| WITHIN EVE LTD→ SC769694 · est 2023 · no financials extracted | — | — | — | — | 2y | — | — |
8 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.
Available from the Pro tier upwards.
See pricing →Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.
Available from the Pro tier upwards.
See pricing →Company details
Registered office
Filing status
Officers (1 active · 0 resigned)
Click a director name to see their full track record across all companies.